MedTrace Logo

Butyrophilins Role in Colon Cancer

NCT04185272 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2025-06-15

No results posted yet for this study

Summary

quantification of BTNL molecules in colon cancer in order to determinate if their could be used as a prognostic marquer

Conditions

  • Colonic Cancer

Interventions

BIOLOGICAL

analysis of BTN and BTNL status

analysis of BTN and BTNL expression in colon cancer and hepatic metastasis

Sponsors & Collaborators

  • Institut Paoli-Calmettes

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-30
Primary Completion
2027-06-30
Completion
2028-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04185272 on ClinicalTrials.gov